734 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Wayfinding Financial LLC

Wayfinding Financial LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 734 shares of the healthcare conglomerate's stock, valued at approximately $371,000.

Other institutional investors have also recently made changes to their positions in the company. M&T Bank Corp raised its position in shares of UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock valued at $128,975,000 after purchasing an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC lifted its position in shares of UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock valued at $4,025,000 after acquiring an additional 1,193 shares in the last quarter. Benjamin Edwards Inc. grew its position in shares of UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock worth $26,060,000 after purchasing an additional 41,308 shares in the last quarter. Parsifal Capital Management LP purchased a new position in UnitedHealth Group in the 3rd quarter worth approximately $21,165,000. Finally, Signal Advisors Wealth LLC grew its holdings in UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after buying an additional 1,051 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Remove Ads

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm's stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

NYSE UNH traded down $2.92 during trading hours on Tuesday, reaching $513.58. The company's stock had a trading volume of 3,014,727 shares, compared to its average volume of 4,091,387. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company's 50-day moving average is $509.10 and its two-hundred day moving average is $545.56. The firm has a market capitalization of $469.78 billion, a price-to-earnings ratio of 33.13, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $5.83 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.64%. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.19%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. Stephens boosted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research report on Thursday, December 5th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price for the company in a research report on Friday, January 10th. Finally, Truist Financial reduced their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.